He Zhu

1095 Jiefang Avenue
Wuhan, 430030, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

SU056 potentiates SULF2 antibody in suppressing cholangiocarcinoma metastasis via SULF2-YBX1-CXCR4 signaling axis.

SU056 potentiates SULF2 antibody in suppressing cholangiocarcinoma metastasis via SULF2-YBX1-CXCR4 signaling axis.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 19, 2025

m6A-Mediated TMCO3 Promotes Hepatocellular Carcinoma Progression by Facilitating the Membrane Translocation and Activation of AKT.

m6A-Mediated TMCO3 Promotes Hepatocellular Carcinoma Progression by Facilitating the Membrane Translocation and Activation of AKT.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 07, 2025

Lysine methylation modifications in tumor immunomodulation and immunotherapy: regulatory mechanisms and perspectives.

Lysine methylation modifications in tumor immunomodulation and immunotherapy: regulatory mechanisms and perspectives.

Journal: Biomarker research
Published: June 11, 2024

VRK2 targeting potentiates anti-PD-1 immunotherapy in hepatocellular carcinoma through MYC destabilization.

VRK2 targeting potentiates anti-PD-1 immunotherapy in hepatocellular carcinoma through MYC destabilization.

Journal: Nature communications
Published: May 02, 2024

GPR56 facilitates hepatocellular carcinoma metastasis by promoting the TGF-β signaling pathway.

GPR56 facilitates hepatocellular carcinoma metastasis by promoting the TGF-β signaling pathway.

Journal: Cell death & disease
Published: April 20, 2024

m6A-Dependent ITIH1 Regulated by TGF-β Acts as a Target for Hepatocellular Carcinoma Progression.

m6A-Dependent ITIH1 Regulated by TGF-β Acts as a Target for Hepatocellular Carcinoma Progression.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 27, 2024

Inhibition of PTPRE suppresses tumor progression and improves sorafenib response in hepatocellular carcinoma.

Inhibition of PTPRE suppresses tumor progression and improves sorafenib response in hepatocellular carcinoma.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 15, 2023

N6-methyladenosine reader YTHDF3-mediated zinc finger protein 41 inhibits hepatocellular carcinoma progression by transcriptional repression of Snail.

N6-methyladenosine reader YTHDF3-mediated zinc finger protein 41 inhibits hepatocellular carcinoma progression by transcriptional repression of Snail.

Journal: MedComm
Published: November 17, 2023

M7G-related tumor immunity: novel insights of RNA modification and potential therapeutic targets.

M7G-related tumor immunity: novel insights of RNA modification and potential therapeutic targets.

Journal: International journal of biological sciences
Published: September 21, 2023

Transcription factor EHF drives cholangiocarcinoma development through transcriptional activation of glioma-associated oncogene homolog 1 and chemokine CCL2.

Transcription factor EHF drives cholangiocarcinoma development through transcriptional activation of glioma-associated oncogene homolog 1 and chemokine CCL2.

Journal: MedComm
Published: August 01, 2023

Identifying the Potential of miRNAs in Houttuynia cordata-Derived Exosome-Like Nanoparticles Against Respiratory RNA Viruses.

Identifying the Potential of miRNAs in Houttuynia cordata-Derived Exosome-Like Nanoparticles Against Respiratory RNA Viruses.

Journal: International journal of nanomedicine
Published: June 14, 2023

Ginger: a representative material of herb-derived exosome-like nanoparticles.

Ginger: a representative material of herb-derived exosome-like nanoparticles.

Journal: Frontiers in nutrition
Published: May 18, 2023
Showing 1-12 of 30

Last Updated: 09/26/2026